REQUEST A DEMO
Total
USD $0.00
Search more companies

Swixx Biopharma OU (Estonia)

Main Activities: Other Business Support Services | All Other Business Support Services
Full name: Swixx Biopharma OU Profile Updated: March 26, 2026
Buy our report for this company USD 19.99 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Swixx Biopharma OU is an enterprise in Estonia, with the main office in Tallinn. It operates in the Other Business Support Services sector. Swixx Biopharma OU was incorporated on October 23, 2014. 25 (2024) employees currently work for Swixx Biopharma OU. There was a net sales revenue increase of 33.89% reported in Swixx Biopharma OU’s latest financial highlights for 2024. There was a total growth of 77.76% in Swixx Biopharma OU’s total assets over the same period. In 2024, Swixx Biopharma OU’s net profit margin decreased by 0.09%.

Headquarters
Parnu mnt 139e/2 Kesklinna linnaosa
Tallinn; Harju county; Postal Code: 11317

Contact Details: Purchase the Swixx Biopharma OU report to view the information.

Basic Information
Total Employees:
Purchase the Swixx Biopharma OU report to view the information.
Registered Capital:
Purchase the Swixx Biopharma OU report to view the information.
Financial Auditors:
Purchase the Swixx Biopharma OU report to view the information.
Incorporation Date:
October 23, 2014
Key Executives
Purchase this report to view the information.
Member of Management Board
Purchase this report to view the information.
Member of Management Board
Purchase this report to view the information.
Member of Management Board
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Swixx Biopharma OU report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
33.89%
Total Operating Revenue
33.89%
Operating Profit
31.6%
EBITDA
30.89%
Net Profit/Loss for the Period
31.64%
Total Assets
77.76%
Total Equity
125.28%
Operating Profit Margin
-0.09%
Net Profit Margin
-0.09%
Return on Equity (ROE)
-21.37%
Cash Ratio
0.18%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?